Alle indikationerne, som er behandlet ovenfor, er omfattet af den nye harmoniserede tekst vedrørende indikationer, der er godkendt af CPMP.
After an assessment of the documentation provided by the MAH and an evaluation of the current EU- wide clinical practices relating to the use of Zocord, the following was considered to be the most suitable harmonised Section 4.1 indications text: